Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Return on Assets (2016 - 2025)

Historic Return on Assets for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to 0.27%.

  • Trinity Biotech's Return on Assets fell 300.0% to 0.27% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.27%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.01% for FY2024, which is 1800.0% down from last year.
  • As of Q2 2025, Trinity Biotech's Return on Assets stood at 0.27%, which was down 300.0% from 0.31% recorded in Q4 2024.
  • Trinity Biotech's 5-year Return on Assets high stood at 0.2% for Q1 2021, and its period low was 0.63% during Q3 2023.
  • In the last 5 years, Trinity Biotech's Return on Assets had a median value of 0.27% in 2025 and averaged 0.25%.
  • In the last 5 years, Trinity Biotech's Return on Assets crashed by -4900bps in 2022 and then skyrocketed by 4100bps in 2024.
  • Trinity Biotech's Return on Assets (Quarter) stood at 0.03% in 2021, then tumbled by -1830bps to 0.47% in 2022, then fell by -29bps to 0.6% in 2023, then surged by 49bps to 0.31% in 2024, then rose by 11bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q2 2025, 0.31% for Q4 2024, and 0.21% during Q3 2024.